Dinosaurs had sex. Fossil nests and eggs, as well as the ways today’s birds and crocodiles reproduce, leave no doubt on that ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

a hit to his reputation and a decrease in his brand's value before his contract renegotiation with the record label this year. The suit added that UMG "understood the recording's inflammatory and ...

FORT WAYNE, Ind. (WANE) — After being arrested in connection to a fatal stabbing at Promenade Park, 23-year-old Lamont Cooley reportedly admitted to the act and said he was trying to protect a ...

NEW YORK, Jan 15 (Reuters) - Drake sued his longtime label on Wednesday, accusing Universal Music Group of defamation for promoting Kendrick Lamar's "Not Like Us," saying the song's false ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

In his book The Mathematical Universe, mathematician William Dunham wrote of John Venn’s namesake legacy, the Venn diagram, “No one in the long history of mathematics ever became better known ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.